News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Glitch Causes Shortage of Nerve Gas Antidote in the U.S.


9/16/2013 8:51:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

For those wondering how the use of chemical gas in Syria affects the US, here is a fresh hook – a Pfizer division is apparently having difficulty making pre-filled syringes that contain antidotes to sarin nerve gas and some US public health officials are concerned about obtaining adequate supplies, The Wall Street Journal writes. While the drugmaker and the federal government are making it a priority to obtain replacement syringes for the military, there have been shortages for ambulances and hospitals that stockpile these for first responders in the US, John Dreyzehner, preparedness chairman for the Association of State and Territorial Health Officials, tells the paper.

Hey, check out all the research scientist jobs. Post your resume today!


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES